Schedule 13G/A

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FY2gfR+ugtPrS+KVmL4NkxL0RSHoW0eAj2FAz2dH498QGk7SZLYR6o4GnITBA7/8 xKtthkWKkfCqWEwkmocUfg== 0001193125-04-024859.txt : 20040217 0001193125-04-024859.hdr.sgml : 20040216 20040217143616 ACCESSION NUMBER: 0001193125-04-024859 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040217 GROUP MEMBERS: BLUEFISH PARTNERS, L.P. GROUP MEMBERS: LLOYD D. RUTH GROUP MEMBERS: MARQUETTE GENERAL II, L.P. GROUP MEMBERS: MARQUETTE VENTURE PARTNERS II, L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALLOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001097264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 541655029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60251 FILM NUMBER: 04607352 BUSINESS ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 BUSINESS PHONE: 3034266262 MAIL ADDRESS: STREET 1: 7000 NORTH BROADWAY STREET 2: SUITE 400 CITY: DENVER STATE: CO ZIP: 80221 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RUTH LLOYD D CENTRAL INDEX KEY: 0001021411 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 520 LAKE COOK ROAD SUITE 450 CITY: DEERFIELD STATE: IL ZIP: 60015 BUSINESS PHONE: 8479401700 MAIL ADDRESS: STREET 1: 520 LAKE COOK ROAD STE 690 CITY: DEARFIELD STATE: IL ZIP: 60015 SC 13G/A 1 dsc13ga.htm SCHEDULE 13G/A Schedule 13G/A


OMB APPROVAL

OMB Number:		3235-0145

Expires:		December 31, 2005

Estimated average burden
hours per response . . . 11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Schedule 13G

(Rule 13d-102)

Under the Securities Exchange Act of 1934

(Amendment No. 3)*

Allos Therapeutics, Inc.

(Name of Issuer)

Common Stock, $0.001 Par Value Per Share

(Title of Class of Securities)

019777101

(CUSIP Number)

December 31, 2003

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 019777101		13G		Page 2 of 10 Pages



1.		NAMES OF REPORTING PERSONS. Marquette Venture Partners II, L.P. S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 36-3820302

2.		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) ¨

3.		SEC USE ONLY

4.		CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5. SOLE VOTING POWER

None

6. SHARED VOTING POWER

None (see Item 4)

7. SOLE DISPOSITIVE POWER

None

8. SHARED DISPOSITIVE POWER

None (see Item 4)


9.		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON None (see Item 4)

10.		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ¨

11.		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.00%

12.		TYPE OF REPORTING PERSON* PN

*SEE INSTRUCTIONS BEFORE FILLING OUT.


CUSIP No. 019777101		13G		Page 3 of 10 Pages



1.		NAMES OF REPORTING PERSONS: Marquette General II, L.P. S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 36-3820303

2.		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) ¨

3.		SEC USE ONLY

4.		CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5. SOLE VOTING POWER

None

6. SHARED VOTING POWER

None (see Item 4)

7. SOLE DISPOSITIVE POWER

None

8. SHARED DISPOSITIVE POWER

None (see Item 4)


9.		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON None (see Item 4)

10.		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ¨

11.		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.00%

12.		TYPE OF REPORTING PERSON* PN

*SEE INSTRUCTIONS BEFORE FILLING OUT.


CUSIP No. 019777101		13G		Page 4 of 10 Pages



1.		NAMES OF REPORTING PERSONS: Bluefish Partners, L.P. (formerly known as LDR Limited Partnership) S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 36-3760176

2.		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) ¨

3.		SEC USE ONLY

4.		CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5. SOLE VOTING POWER

None

6. SHARED VOTING POWER

None (see Item 4)

7. SOLE DISPOSITIVE POWER

None

8. SHARED DISPOSITIVE POWER

None (see Item 4)


9.		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON None (see Item 4)

10.		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ¨

11.		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.00%

12.		TYPE OF REPORTING PERSON* PN

*SEE INSTRUCTIONS BEFORE FILLING OUT.


CUSIP No. 019777101		13G		Page 5 of 10 Pages



1.		NAMES OF REPORTING PERSONS: Lloyd D. Ruth S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: ###-##-####

2.		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) ¨

3.		SEC USE ONLY

4.		CITIZENSHIP OR PLACE OF ORGANIZATION United States of America

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5. SOLE VOTING POWER

None

6. SHARED VOTING POWER

None (see Item 4)

7. SOLE DISPOSITIVE POWER

None

8. SHARED DISPOSITIVE POWER

None (see Item 4)


9.		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON None (see Item 4)

10.		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ¨

11.		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.00%

12.		TYPE OF REPORTING PERSON* IN

*SEE INSTRUCTIONS BEFORE FILLING OUT.


CUSIP No. 019777101		13G		Page 6 of 10 Pages

Item 1(a)

Name of Issuer:

Allos Therapeutics, Inc. (“Allos”)

Item 1(b)

Address of Issuer’s Principal Executive Offices:

11080 CirclePoint Road

Suite 200

Westminster, CO 80020

Item 2(a)

Name of Person Filing:

This Schedule 13G is being jointly filed by each of the following persons pursuant to Rule 13-d(1)(k) promulgated by the Securities and Exchange Commission pursuant to Section 13 of the Securities and Exchange Act of 1934, as amended (the “Act”): (i) Marquette Venture Partners II, L.P. (“MVP II”), a Delaware limited partnership, by virtue of its direct beneficial ownership of 0 shares of common stock, par value $0.001 per share (the “Common Stock”), of Allos; (ii) Marquette General II, L.P. (“MG II”), a Delaware limited partnership, as the sole general partner of MVP II; (iii) Bluefish Partners, L.P. (“Bluefish”), a Delaware limited partnership, as a general partner of MG II; and (iv) Lloyd D. Ruth (“Mr. Ruth”), as an affiliate of Bluefish. MVP II, MG II, Bluefish, and Mr. Ruth are hereinafter collectively referred to as the “Reporting Persons.”

The Reporting Persons have entered into a Joint Filing Agreement, dated February 13, 2004, a copy of which is filed herewith pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.

Item 2(b)

Address of Principal Business Office or, if none, Residence:

The address of the principal business office of each of the Reporting Persons is:

676 N. Michigan Avenue

Suite 3120

Chicago, Illinois 60611

Item 2(c)

Citizenship:

MVP II, MG II and Bluefish are limited partnerships organized under the laws of Delaware. Mr. Ruth is a United States citizen.

Item 2(d)

Title of Class of Securities:

Common Stock, $0.001 par value per share.


CUSIP No. 019777101		13G		Page 7 of 10 Pages

Item 2(e)

CUSIP No.:

019777101

Item 3

If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

The persons filing are not described in any category listed under this item.

Item 4

Ownership:

(a) Amount beneficially owned:

MG II is the sole general partner of both MVP II; Bluefish is the general partner of MG II; and Mr. Ruth is an affiliate of Bluefish. As a result of such relationships, MG II and Bluefish and Mr. Ruth may be deemed to share voting and dispositive power with respect to the shares held by MVP II. The information on the cover pages are incorporated herein by reference.

Each Reporting Person expressly disclaims beneficial ownership of any shares of Common Stock beneficially owned by each other Reporting Person.

(b) Percentage of class:

All ownership percentages of the securities reported herein are based upon 25,913,592 shares of common stock outstanding as of November 4, 2003, as disclosed in Allos’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2003.


(i)		sole power to vote or direct the vote: See Item 5 of the cover pages.

(ii)		shared power to vote or direct the vote: See Item 6 of the cover pages.

(iii)		sole power to dispose of or direct the disposition of: See Item 7 of the cover pages.

(iv)		shared power to dispose or direct the disposition of: See Item 8 of the cover pages.

Item 5

Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X].


CUSIP No. 019777101		13G		Page 8 of 10 Pages

Item 6

Ownership of More Than Five Percent on Behalf of Another Person:

See response to Item 4.

Item 7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:_

Not applicable.

Item 8

Identification and Classification of Members of the Group:

Not applicable.

Item 9

Notice of Dissolution of Group:

Not applicable.

Item 10

Certification:

Not applicable.


CUSIP No. 019777101		13G		Page 9 of 10 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 13, 2004


MARQUETTE VENTURE PARTNERS II, L.P. MARQUETTE GENERAL II, L.P. BLUEFISH PARTNERS, L.P.

By:		/s/ Lloyd D. Ruth
		Lloyd D. Ruth as authorized signatory


CUSIP No. 019777101		13G		Page 10 of 10 Pages

Exhibit A

AGREEMENT REGARDING THE JOINT FILING OF

SCHEDULE 13G

The undersigned hereby agree as follows:

(i) Each of them is individually eligible to use the Schedule (the “Schedule 13G”) to which this Exhibit is attached, and such Schedule 13G is filed on behalf of each of them; and

(ii) Each of them is responsible for the timely filing of such Schedule 13G and any subsequent amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness and accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

Dated: February 13, 2004


MARQUETTE VENTURE PARTNERS II, L.P. MVP II AFFILIATES FUND, L.P. MARQUETTE GENERAL II, L.P. BLUEFISH PARTNERS, L.P.

By:		/s/ Lloyd D. Ruth
		Lloyd D. Ruth as authorized signatory

/s/ Lloyd D. Ruth
LLOYD D. RUTH

-----END PRIVACY-ENHANCED MESSAGE-----